Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06287398
Title Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Australasian Leukaemia and Lymphoma Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.